Join to View Full Profile
101 Cb 7512Chapel Hill, NC 27599
Phone+1 984-974-8418
Dr. Shen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Colette Shen is a radiation oncologist located in Chapel Hill, NC, and serves as an Associate Professor at the University of North Carolina Hospitals. She completed her residency in Radiation Oncology at Johns Hopkins University in 2017, after graduating from the Perelman School of Medicine at the University of Pennsylvania in 2012. Her research contributions include several publications focusing on tumor-associated outcomes and radiation therapy techniques, appearing in esteemed journals such as the Journal of Neuro-Oncology and International Journal of Radiation Oncology, Biology, Physics. Dr. Shen is also actively involved in clinical trials, serving as a sponsor-investigator and principal investigator in studies related to radiosurgery and advanced cancer treatments.
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2013 - 2017
Perelman School of Medicine at the University of PennsylvaniaClass of 2012
Certifications & Licensure
NC State Medical License 2017 - 2026
DC State Medical License 2012 - 2013
VA State Medical License 2012 - 2013
American Board of Radiology Radiation Oncology
Clinical Trials
- MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets Start of enrollment: 2019 Dec 04
- Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Roles: Contact
- Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases Start of enrollment: 2022 Mar 09
Roles: Sponsor-Investigator, Contact, Principal Investigator
Publications & Presentations
PubMed
- Commentary: Long-Term Outcomes After CyberKnife Radiosurgery for Nonfunctioning Pituitary Adenomas.Boyi Li, Colette Shen, Dominique Higgins
Neurosurgery. 2025-04-01 - 1 citationsRedefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative Risk.Ryan T Morse, Tyler J Nelson, Hannah C Liu, Prangrawee Sangchan, Bhargava Chitti
International Journal of Radiation Oncology, Biology, Physics. 2025-03-01 - Association between tumor location and toxicity outcomes after stereotactic radiosurgery for brain metastases.Boya Wang, Alexandra Bukowski, Orit Kaidar-Person, James M Choi, Deanna M Sasaki-Adams
Journal of Neuro-Oncology. 2025-01-01
Press Mentions
NANOBIOTIX to Present First Survival Data from Priority Head and Neck Cancer Program Among Five Presentations at the 2021 Annual Meeting of the American Society for Radiation OncologyOctober 7th, 2021- NANOBIOTIX Reports New Data for Potential First-in-Class Radioenhancer NBTXR3 in Combination with Anti-PD-1 Showing Local or Distant Tumor Regression in 76.9% of Evaluable Patients Regardless of Prior Anti-PD-1 ExposureJune 3rd, 2021
- AACR-AHNS Head and Neck Cancer Conference: Highlights from the Cutting EdgeAugust 4th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
